CompletedNot Applicable

Clinical Trial for Evaluating Sage-Based Mouthrinse

Switzerland45 participantsStarted 2016-10

Plain-language summary

The investigators aim to evaluate a sage-based mouthrinse (Dr. Hauschka Med, Mundspülung Salbei) whether it is less or equal effective in alleviating inflammatory signs of intra-oral mucosa and gingiva than an water/alcohol-based taste adjusted placebo in patients dependent on ADL. Randomization in treatment A (mouthwash with active agent, n=24) or treatment B (placebo mouthwash, n=24) Supervised use of mouthwash A or mouthwash B over 6 weeks 1x/day additional to habitual oral hygiene protocol. The main outcome parameter will be Sulcus Bleeding Index SBI.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able to give informed consent, i.e. no legal guardian appointed * Willing to participate * Depended on their ADLs (IADL)(24) * Sulcus Bleeding Index (SBI) \> 50% Exclusion Criteria: * Allergy to one of the components * Edentulous * Alcohol dependency * Prescription of antibiotics and/ or immunosuppressives (e.g. glucocorticoids) Anti-inflammatory mouthrinse -

What they're measuring

Sulcus Bleeding Index

Timeframe: six weeks

Trial details

NCT IDNCT02830802

SponsorUniversity of Bern

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-10

View on ClinicalTrials.gov More Stomal Bleeding trials